Table 1

Clinical characteristics and treatment of the patients with inflammatory bowel disease at the time of jejunal and colonic biopsies

GroupAge (y)SexTime after diagnosis (y)ExtensionCourseSurgery1-150Treatment
UC27M10Left colonIntermittentNSSZ
UC22M8PancolitisContinuousNMTX
UC53M11PancolitisContinuousNPRE
UC42F4Left colonIntermittentNSSZ
UC53F8Left colonIntermittentNSSZ
UC38M4Left colonIntermittentNSSZ
UC42M7PancolitisIntermittentNSSZ
UC58M5Left colonIntermittentNPRE
UC46F4Left colonIntermittentN0
UC40M5Left colonIntermittentNSSZ
CD21M3IleocolitisIntermittentN0
CD36F13IleocolitisContinuousYPRE
CD55F3IleocolitisContinuousNPRE+MNZ
CD56F5ColitisIntermittentNAZA
CD46M6IleocolitisIntermittentN0
CD20F1IleocolitisIntermittentNPRE
CD38F5IleocolitisIntermittentYPRE
CD36F5ColitisIntermittentNAZA
CD45M6IleocolitisIntermittentNPRE+MNZ
  • 1-150 N, no surgery; Y, at least one operation.

  • UC, ulcerative colitis; CD, Crohn's disease; PRE, prednisone; AZA, azathioprine; MTX, methotrexate; SSZ, sulphasalazine; MNZ, metronidazole; 0, no drug therapy.